Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. mitrep

MITrep

Automated mini-invasive surgical approach to the treatment of mitral insufficiency

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MITrep project word cloud

Explore the words cloud of the MITrep project. It provides you a very rough idea of what is the project "MITrep" about.

hours    ring    starting    worldwide    leaking    moderate    75    normal    patients    feasibility    afflicts    time    palpitations    surgery    repair    abnormally    improvement    sudden    tagged    10    trial    severe    returns    preventing    double    mini    hospitalization    transfemoral    gold    cmi    goes    insufficiency    usa    uses    symptoms    stroke    care    times    valvuloplasty    device    ambition    breath    operations    tricuspid    chronic    reduce    followed    standard    rate    vs    nov    intensive    safety    valve    operation    mitral    blood    hospital    driver    dramatic    surgeries    leak    inoperable    company    replicable    skilled    aortic    affix    post    icu    80k    300    validate    context    aged    halve    surgical    healthcare    fatigue    mainly    death    anchored    80    age    fragile    patient    elderly    unbearable    half    lack    2030    efficiency    surgeons    annuloplasty    days    first    risk    deployment    holds    specialist    transapical    tested    heart    once    racing    30k    automatically    prevalence    heavy    patented    shortness    invasive    mitrep    error   

Project "MITrep" data sheet

The following table provides information about the project.

Coordinator		 CMI NOV 

Organization address
address: BATIMENT 4 PUISSANCE 3 ZA CHAVANON
city: MONISTROL SUR LOIRE
postcode: 43120
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country France [FR]
 Project website http://www.cmi-nov.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CMI NOV FR (MONISTROL SUR LOIRE) coordinator 50˙000.00

Map

 Project objective

Mitral valve insufficiency is a heart condition, where blood is abnormally leaking out of the mitral valve. This condition mainly afflicts the elderly patients: - 80% of patients aged 80 show moderate symptoms (chronic fatigue, shortness of breath, palpitations, racing heart rate) - 10% of patients above 75 with severe symptoms are at risk of a sudden death (stroke) within 5 years. - Prevalence will double by 2030. Mitral insufficiency is treated with open heart surgery (300,000 operations/year in the EU and the USA) followed by intensive care. But this operation is unbearable for fragile patients. Half of the patients above 75 are tagged inoperable because of their age. Less invasive repair surgeries have been tested (annuloplasty by transfemoral surgery) but lack efficiency and safety and require highly skilled surgeons (not available in each hospital). In this context, the company CMI’nov has developed MITrep, the first patented mini-invasive surgical device that automatically goes to the mitral valve with no trial and error to affix a leak-preventing ring on the valve. It uses the transapical approach. Once the ring is anchored, the mitral valve returns to normal activity. No heavy post-surgery effects are expected. No intensive care required.

MITrep can be used by any surgeons : no need to be a mitral valve specialist. It will allow to halve the operation time (from 5 hours to less than 2 hours), reduce hospitalization time to 3 days (vs 5-8 days with 2 days in ICU) and cost about three times less than open heart surgery (30k€ vs 80k€). It means a dramatic cost reduction for healthcare systems and a real improvement of the care of the elderly patient.

This project holds the ambition to build a new gold standard in valvuloplasty worldwide, starting with mitral repair and replicable to aortic and tricuspid valve repair. It is also a value driver for CMI’nov. The Phase 1 project will validate the feasibility of MITrep before scale-up and deployment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MITREP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MITREP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More  

MACCO (2019)

Bring social robots into reality with the first real world leading bartender (MACCO)

Read More